As of 2026-02-02, the EV/EBITDA ratio of Blueprint Medicines Corp (BPMC) is -54.80. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BPMC's latest enterprise value is 8,637.68 mil USD. BPMC's TTM EBITDA according to its financial statements is -157.63 mil USD. Dividing these 2 quantities gives us the above BPMC EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.3x - 13.0x | 11.8x |
| Forward P/E multiples | 10.9x - 22.5x | 12.4x |
| Fair Price | (31.65) - (35.74) | (33.66) |
| Upside | -124.4% - -127.6% | -126.0% |
| Date | EV/EBITDA |